Hypertension - the silver bullet of medicine
In this special report, learn about The Essentials of Hypertension
Hypertension is the number one cause of years of life lost, and, perhaps more importantly, years of healthy living lost. It causes at least half of all heart attacks and strokes and is the major driver of heart failure. As cardiologists, much of our working life is spent dealing with the downstream consequences of hypertension... Read more
Learning objectives
- Understand why hypertension is a major global problem
- How to establish an RDN referral network
- How to use currently available devices
Table of Contents
The guidelines underline the importance of out-of-office measurements and promote patient-centred care that employs shared decision-making strategies. Renal denervation has been upgraded to a class II recommendation and may now be considered for patients with uncontrolled hypertension who are willing to undergo the procedure.
Explore the global challenge of hypertension, affecting one in three adults, and the strategies for screening, diagnosis, and management, including lifestyle modifications, pharmacotherapy, and device-based treatments, as outlined by Sofie Brouwers.
After the inclusion of renal denervation in the 2023 European Society of Hypertension guidelines, Andrew Sharp and Felix Mahfoud discuss patient selection, best practices, safe use of contrast, device choices, and follow-up care.
Explore the essential steps in setting up a Renal Denervation programme, including team-building, patient selection, comprehensive care, and long-term follow-up, as discussed by Andrew Sharp and Valérie Duchatelle.
In this case report, we explore an advanced RDN technique—ultrasound energy—that was employed to manage severe hypertension in patients with complex medical histories.
In this case report, we explore an advanced RDN technique—radiofrequency energy—that was employed to manage severe hypertension in patients with complex medical histories.
In this article, Atul Pathak and Julien Adjedj assess the future of RDN in Europe, considering recent technological, clinical, and regulatory developments.
This special report on hypertension is available thanks to the support of Recor Medical.
PCR develops independent educational programmes.